Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Emposat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only gives contextual membership rationale that Emposat provides ground-station access used in connection with a surveillance satellite, which is too indirect to support a durable positive investment thesis without direct within the recent evidence window business evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat. Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard. |
| 302 | EnduroSat lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the selected recent evidence window, despite membership rationale describing EnduroSat as a space infrastructure and satellite-constellation builder. Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here. Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment. |
| 303 | EON Space Labs lowweak | Opp 1 Risk 3 | Thesis: No positive thesis is supportable from the scoring evidence fields because no direct positive evidence are provided. Why now: Why now is stronger than for most names here because the phase2 rationale specifically ties EON Space Labs to a PSLV failure context via article: implying a concrete event rather than generic company context. However, conviction remains low because the reviewed sources omits the underlying event summary and dates in the evidence exposed here. Caveats: The adverse signal appears only in phase2 rationale, not in direct negative evidence. No article summary, quote, or timing detail is provided in the scoring fields. Impact magnitude on EON specifically cannot be quantified from these reviewed sources alone. |
| 304 | FOSSA Systems lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale says FOSSA Systems has launched 24 satellites, is deploying an 80-satellite constellation, and has defense customers, but there are no available direct positive evidence or dated representative articles within the reviewed sources for scoring, so opportunity remains only a watchlist possibility. Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources. Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale. |
| 305 | GalaxEye Space Solutions Private Ltd lowweak | Opp 1 Risk 2 | Thesis: The company belongs in the cohort as an Earth observation / SAR startup, but these reviewed sources provide no available within the recent evidence window directional evidence to support a strong 1 year+ opportunity thesis. Why now: There is no within the recent evidence window evidence available for this entity in the reviewed sources; recency of any business progress is uncertain. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff for this entity. Membership rationale references article IDs, and: but no article summaries or direct evidence are included in these reviewed sources for citation-level use. Scores are constrained by absence of directional evidence, not by a proven negative business outcome. |
| 306 | GE Aerospace lowweak | Opp 1 Risk 1 | Thesis: No reviewed sources-supported positive thesis is available. The company is only described as appearing in generic 'space stocks' context, while direct positive evidence after the 90-day recent evidence window is absent. Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported. Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement. |
| 307 | Gilat Satellite Networks Ltd. lowweak | Opp 1 Risk 1 | Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a positive 1 year+ opportunity thesis. Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources. Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them. |
| 308 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources offers no direct positive company-specific evidence within the available scoring set. The membership rationale says Hensoldt appears in a market report as one of many key players in the space situational awareness market, but that is article-level market-list context rather than direct business evidence, and no available evidence remain after recent evidence window. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 309 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: A limited positive angle exists because the membership rationale says a HEO camera achieved sub-5-meter resolution in Sidus Space's earnings context, implying technical relevance (: and: unavailable in reviewed sources). However, this appears indirect and counterparty/component context rather than direct company evidence, so opportunity remains low. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 310 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available. The reviewed sources say Hermeus is only mentioned as one of several companies expanding in California in an article about Skydio, which is too indirect to support a durable positive thesis. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 311 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources places HughesNet within satellite broadband and communication services context via EchoStar, but there is no direct reviewed evidence in the 90-day window to support a differentiated 1 year+ opportunity thesis. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 312 | Impulso lowweak | Opp 1 Risk 1 | Thesis: There is no direct positive evidence in the available scoring set. The reviewed sources say Impulso is mentioned only as GalaxEye's distribution agreement counterparty, which does not establish Impulso's own business opportunity. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 313 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity exists if the previously referenced multi-launch agreement for servicing satellites remains active, but the reviewed sources provide no retained within the recent evidence window positive evidence to support a current thesis. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 314 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current positive thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 315 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported from retained evidence because the reviewed sources contain no direct positive rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 316 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No positive thesis can be supported because there is no retained direct positive evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 317 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct positive evidence was available inside the 90-day recent evidence window, so there is no supportable positive 1 year+ opportunity thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 318 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: Kepler may have long-horizon potential because the membership rationale says it operates an optical relay satellite network and is prime contractor on ESA HydRON optical communications work, but there is no available within the recent evidence window evidence in these reviewed sources to substantiate a directional score. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 319 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence hints only that Kessler Dynamics was listed in a spacetech accelerator with themes including rocket propulsion, satellites, and space energy, but no in-recent evidence window direct evidence or article is provided, so there is no supported positive thesis. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 320 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable opportunity thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
Risk view
Showing rows 221-240 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 221 | Spacety lowweak | Opp 2 Risk 2 | Thesis: There is no usable in-window article or evidence detail in the reviewed sources to validate the company’s current operating status, financing trajectory, or any adverse development, so the main risk is evidence absence rather than proven business trouble. Why now: There is no dated evidence retained after recent evidence window for Spacety in these reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency is uncertain. Caveats: No representative articles or evidence are provided after recent evidence window. The only support is the phase2 membership rationale, which is weaker than direct event/fact evidence and does not provide /article summaries here. Because there is no in-window evidence, scores remain low on both axes. |
| 222 | Spacium lowweak | Opp 1 Risk 2 | Thesis: No direct negative evidence is present; the main issue is stale evidence and resulting uncertainty about current momentum or business state. Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026. Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof. |
| 223 | SpinLaunch lowweak | Opp 2 Risk 2 | Thesis: Novel launcher and constellation buildout imply execution risk, but these reviewed sources provide no direct negative evidence within the recent evidence window. Why now: Why-now is weak because the reviewed sources show 0 evidence kept after the 90-day recent evidence window, so recency cannot be established from local evidence. Caveats: Phase2 membership rationale references and, but no article summaries or direct evidence are included, so they cannot be cited as factual support beyond noting the reviewed sources rationale. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score kept low because positive thesis is not directly grounded in usable article evidence in these reviewed sources. |
| 224 | SSC Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence risk is mainly lack of evidence visibility rather than documented negative developments. Without available direct evidence, current contract status, capex burden, and follow-on demand are unclear. Why now: Why now is weak because no evidence survived into the ranking reviewed sources despite the membership rationale. Caveats: Phase-2 membership rationale references: but no or direct evidence row is available here. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Do not infer opportunity from mission association alone without available evidence. |
| 225 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 2 | Thesis: Risk is mostly uncertainty risk because no kept recent evidence window evidence establish financing, contracts, milestones, or adverse developments. Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use. Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence. |
| 226 | Starcloud lowweak | Opp 4 Risk 2 | Thesis: The same rationale suggests category ambiguity and execution risk: orbital AI/data-center activity may be conceptually ambitious, but the reviewed sources does not prove commercialization, deployment, or durable demand. No direct adverse evidence is available, so risk remains moderate and evidence-light rather than event-driven. Why now: If the fundraising and product positioning are recent, they could support a multi-quarter buildout story, but the reviewed sources explicitly shows zero available evidence after recent evidence window, so recency and sequencing cannot be confirmed. Caveats: Most supportive facts appear only in membership rationale, not available evidence. Reported funding cannot be treated as fully validated without direct article support in reviewed sources. No, quote, or dated direct summary is available. |
| 227 | Stelleo lowweak | Opp 4 Risk 2 | Thesis: Risk remains modest because the reviewed sources offers no adverse evidence, but also no proof of contracts, funding, customer traction, or scaling milestones. That makes the opportunity early-stage and low-conviction. Why now: The article is within the recent evidence window and dated May 25, 2026, but it is a company-site style description rather than an independently reported business event, so it supports relevance more than momentum Evidence
Caveats: Evidence is article-level company context, not a direct commercial milestone. No direct traction, financing, or contract evidence is provided. Same-article repeated rows are not independent confirmation. |
| 228 | SWISSto12 lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources contain no retained article/evidence detail after recent evidence window to confirm deliveries, customer adoption, financing, or execution setbacks, so business risk cannot be judged confidently. Why now: There is no dated evidence retained after recent evidence window for SWISSto12. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so the timing case is not established from these reviewed sources. Caveats: Assessment relies only on the reviewed sources' membership rationale, not direct quoted event/fact evidence with support. No representative articles are included despite article IDs being referenced in the rationale. Potential opportunity could be meaningful, but evidentiary support inside these reviewed sources is too thin for a stronger score. |
| 229 | Terran Orbital lowweak | Opp 1 Risk 2 | Thesis: Risk scores slightly above minimal only because evidence absence is meaningful for ranking confidence and because the reviewed sources gives no current direct positive operating or contract evidence inside the recent evidence window. There is still no direct adverse event in the reviewed sources. Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence. Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence. |
| 230 | The Exploration Company lowweak | Opp 5 Risk 2 | Thesis: Main risk is evidence thinness and uncertain recency: the reviewed sources contain no direct negative evidence, but the only business evidence is undated supporting article context, so current contract status and execution progress are uncertain. Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious. Evidence
Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence. |
| 231 | True Anomaly Centennial lowweak | Opp 3 Risk 2 | Thesis: Risk remains moderate because the reviewed sources provide no direct available evidence after recent evidence window to confirm award economics, schedule, or follow-on conversion. Why now: Government program selection could matter over 1 year+, but the reviewed sources does not provide surviving evidence with timing details after recent evidence window. Caveats: No -bearing direct evidence row is available for the referenced Andromeda selection article. Selection does not prove revenue realization or contract scale. |
| 232 | Umbra mediummedium | Opp 5 Risk 2 | Thesis: The main risk in these reviewed sources is evidentiary rather than business-specific: there is no direct negative evidence, but also no direct structured positive event row such as a contract, financing, or milestone within the recent evidence window. Opportunity therefore rests on supporting article context rather than stronger company-specific event evidence. Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong. Evidence
Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring. |
| 233 | United Launch Alliance lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available, so there is no supported negative thesis from these reviewed sources alone. Why now: The membership rationale cites articles: and: but no article summaries or evidence are available after recent evidence filtering for ranking. Caveats: Launch-industry membership is not itself a directional thesis. Coverage debug shows zero evidence after recent evidence window despite many considered articles. No direct contract, launch cadence, backlog, or failure evidence is available in these reviewed sources. |
| 234 | Viasat, Inc. mediummedium | Opp 4 Risk 2 | Thesis: Risk remains moderate because the reviewed sources provide only weak supporting article context rather than direct structured company events, limiting confidence in scope, economics, and timing of impact. Why now: Recent context exists within the recent evidence window: is dated June 11, 2026 and states Viasat was among operators selected under a combined $437.7 million award and has a defined supplier stack for its PTS-G satellite, which could matter over a 1 year+ horizon. Source date basis is source date. Evidence
Caveats: This is supporting article context only; the reviewed sources classifies it under weak context, so it is weaker than direct event/fact evidence. Same article appears in two weak-context rows and should not be treated as independent confirmation. An older Viasat company-hosted article exists but is outside recent evidence window, February 29, 2024 |
| 235 | Voyager Technologies Inc. lowweak | Opp 2 Risk 2 | Thesis: A mild risk prior exists only from uncertainty: despite many articles considered, no retained evidence remains after recent evidence window, so no current adverse thesis is established and business-state recency is unclear. Why now: There is no citable within the recent evidence window evidence in the reviewed sources to justify a strong 1 year+ 'why now' despite broad historical article coverage. Caveats: Phase-2 rationale references: and: but no or summaries are provided here. Coverage debug shows 78 articles considered but 0 article IDs after recent evidence window and 0 available evidence. Ticker ambiguity exists in aliases (VOYG, VYGR), but the required output ticker is VOYG. |
| 236 | VSBLTY Groupe Technologies Corp. lowweak | Opp 2 Risk 2 | Thesis: The same rationale implies adjacency rather than a clearly established core space operator role, creating execution and relevance risk, but no material adverse event evidence is available after recent evidence filtering. Why now: No reviewed sources-grounded timing support is available for why this matters now over a 1 year+ horizon; the reviewed sources retains zero evidence after the cutoff and provides no citable for article. Caveats: Reviewed evidence is limited to a membership rationale; there are no representative article summaries, or evidence after recent evidence window. The cited article id is not accompanied by a in the reviewed sources, so it cannot be used for factual claim citation. Slightly higher opportunity/risk than some peers reflects adjacency language in the reviewed sources rationale only, not strong direct evidence. |
| 237 | Xdlinx lowweak | Opp 2 Risk 2 | Thesis: No direct negative evidence is present; the practical risk to ranking is simply insufficient current evidence. Why now: The reviewed sources includes no representative article or retained evidence within the 90-day recent evidence window, so recency and current status are uncertain for Xdlinx in this screen. Caveats: No retained evidence after recent evidence window. Phase-2 membership support alone is not enough for a stronger score. |
| 238 | XDLINX Space Labs lowweak | Opp 2 Risk 2 | Thesis: Risk is modestly elevated versus some peers because the company appears only once in the reviewed sources, and the lack of retained recent evidence means the claimed business standing cannot be validated or updated within the recent evidence window. Why now: No current catalyst is evidenced; coverage after recent evidence window is empty. Caveats: Reviewed evidence mentions: but provides no. Higher-revenue claim is only from membership rationale and may not be current. No retained structured positive or negative evidence after recent evidence window. |
| 239 | Xona Space lowweak | Opp 3 Risk 2 | Thesis: Risk is mainly execution and proof-of-delivery risk because the surviving evidence is undated company context without dated commercial milestones, customers, or financing in the reviewed sources. Why now: Why now is weak: the only surviving evidence is undated, so recency-sensitive claims are uncertain Evidence
Caveats: Evidence is undated and should not be treated as recency proof. No direct positive event or traction evidence is available. Opportunity case is strategic but low-conviction. |
| 240 | ADAspace lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Risk remains low-scored due to lack of evidence rather than demonstrated safety. Why now: There is no usable within the recent evidence window evidence in the reviewed sources; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for ADAspace. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. No direct positive or negative evidence survived the 90-day recent evidence window. |